ctrl K

Watchlist Price Alert

MIRA Pharmaceuticals Inc. (MIRA)

NASDAQ: MIRA · Real-Time Price · USD

1.25

0.04 (3.31%)

At close: Jul 02, 2025, 3:59 PM

MIRA Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	8.53M	n/a	n/a	n/a
Gross Profit	n/a	-8.53M	n/a	n/a	n/a
Operating Income	-8.02M	-8.53M	-7.05M	-2.15M	-67.63K
Interest Income	n/a	n/a	n/a	n/a	n/a
Pretax Income	-7.85M	-11.98M	-7.06M	-2.18M	-67.99K
Net Income	-7.85M	-11.98M	-7.06M	-2.18M	-67.99K
Selling & General & Admin	4.71M	6.95M	2.99M	770.12K	52.98K
Research & Development	3.31M	1.57M	2.35M	684.45K	14.65K
Other Expenses	n/a	0.00	-1.7M	-697.6K	n/a
Operating Expenses	8.02M	8.53M	7.05M	2.15M	67.63K
Interest Expense	165.67K	3.46M	10.25K	24.37K	364.00
Selling & Marketing Expenses	n/a	453.55K	n/a	n/a	52.82K
Cost & Expenses	n/a	8.53M	7.05M	2.15M	67.63K
Income Tax Expense	n/a	n/a	-7.05K	-2.15K	-202.89
Shares Outstanding (Basic)	15.44M	18.57M	14.75M	14.75M	14.75M
Shares Outstanding (Diluted)	15.44M	18.57M	14.75M	14.75M	14.75M
EPS (Basic)	-0.51	-0.65	-0.48	-0.15	-0.00
EPS (Diluted)	-0.51	-0.65	-0.48	-0.15	-0.00
EBITDA	-7.85M	n/a	-7.05M	-2.15M	n/a
EBIT	-7.69M	-8.53M	-7.05M	-2.15M	-202.89K
Depreciation & Amortization	-165.67K	8.53M	7.05M	2.15M	202.89K